An analgesic, commonly known as a painkiller, is any member of the group of drugs used to achieve relief from pain. Unlike anesthetics, which eliminate sensation entirely, analgesics are designed to reduce the perception of pain without causing loss of consciousness or significantly altering other senses.
1. How Do Painkillers Work?
Painkillers target the pain pathway at different stages, from the site of injury to the brain’s processing centers.
Peripheral Action: Non-opioid painkillers (like NSAIDs) work at the site of injury by inhibiting cyclooxygenase (COX) enzymes. This stops the production of prostaglandins, the chemicals that trigger pain and inflammation signals.
Central Action: Opioid painkillers bind to specific mu-opioid receptors in the brain and spinal cord. This effectively “muffles” the pain signals as they travel to the brain, while also altering the emotional response to pain.
2. Major Classifications of Painkillers
The pharmaceutical industry categorizes painkillers based on their chemical structure and therapeutic strength:
| Category | Description | Common Examples |
| Non-Narcotic (Non-Opioids) | Best for mild-to-moderate pain and inflammation. Generally non-addictive. | Paracetamol (Acetaminophen), Ibuprofen, Aspirin, Diclofenac. |
| Narcotic (Opioids) | Powerful drugs for severe, acute, or chronic pain (e.g., post-surgery or cancer). | Morphine, Codeine, Fentanyl, Tramadol. |
| Adjuvant Analgesics | Drugs primarily designed for other conditions (like seizures) that also relieve specific pain. | Gabapentin (for nerve pain), Amitriptyline. |
| Topical Painkillers | Externals applied directly to the skin for localized relief without stomach irritation. | Diclofenac gel, Lidocaine patches, Capsaicin cream. |
3. Significance of Painkiller Manufacturing in India (2026)
As of 2026, India is the global powerhouse for analgesic production, driven by a strategic shift toward non-addictive and targeted delivery systems.
Massive Production Scale: India produces a significant portion of the world’s generic Paracetamol and Ibuprofen, ensuring global affordability during health crises.
Focus on Non-Opioid Innovation: With the global push to reduce opioid dependency, Indian CDMOs are leading the development of Fixed-Dose Combinations (FDCs) that combine different non-addictive mechanisms for superior pain relief.
Specialized Delivery Systems: Indian facilities are at the forefront of producing painkillers in advanced formats like Pre-filled Syringes (PFS) for rapid post-operative care and Lyophilized Injections for emergency stability.
Growth in Topicals: The “Externals” market in India is booming, with manufacturers developing high-penetration gels and sprays that provide relief without systemic side effects.
4. Why Healthy Inc. is Your Strategic Sourcing Partner
Navigating the high-volume painkiller market requires a partner who understands both the chemistry and the compliance. Healthy Inc. acts as your technical bridge:
Strategic Sourcing Hub: We are associated with multiple state-of-the-art manufacturing units. Whether you need bulk supply of Paracetamol tablets, sterile Diclofenac injections, or specialized Analgesic gels, we match you with the right facility.
Pharmacist-Led Technical Vetting: We provide “straight answers” on formulation stability and purity. Our team vets every batch to ensure it meets the highest international WHO-GMP standards.
Regulatory & Dossier Mastery: We simplify your market entry by providing full CTD/ACTD dossiers, stability data, and all necessary export certifications.
Market-Ready Solutions: Through our associated network, we offer flexible Private Labeling (OEM), allowing you to launch your own brand of high-quality painkillers with professional packaging and flavoring.
Showing all 11 results
Aceclofenac ,Paracetamol & Trypsin-Chymotrypsin 150000AU Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated, Enteric-Shielded Tablet to ensure the enzymes are protected from stomach acid and absorbed in the intestine.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint pain and physical swelling of the tissues. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Trypsin-Chymotrypsin 150,000 AU The Enzyme Payload: Resolves inflammation and clears edema to accelerate tissue repair. Aceclofenac , Paracetamol and Serratiopeptidase Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated, Enteric-Shielded Tablet to ensure the enzyme remains active through the stomach acid.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint and tissue inflammation and stiffness. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Serratiopeptidase 15 mg The Enzyme Payload: Resolves inflammation and clears edema to accelerate tissue repair. Diclofenac Tablets
FreeProduct Composition & Strength
We supply this product as Enteric Coated (Gastro-Resistant) Tablets or Sustained Release (SR) Tablets.
Active Ingredient Strength (Standard) Formulation Role Diclofenac Sodium USP/BP 25 mg Enteric Coated Pediatric / Mild Pain Diclofenac Sodium USP/BP 50 mg Enteric Coated Standard Acute Dose Diclofenac Sodium USP/BP 75 mg Enteric Coated / SR Intermediate / Injection Switch Diclofenac Sodium USP/BP 100 mg Sustained Release (SR) Once Daily (Chronic Pain) Hydrocortisone Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.
Active Ingredient Strength Primary Use Hydrocortisone Sodium Succinate USP/BP Equivalent to 100 mg Hydrocortisone Standard Adult / Pediatric Emergency Hydrocortisone Sodium Succinate USP/BP Equivalent to 250 mg Severe Asthma / Sepsis Pulse Hydrocortisone Sodium Succinate USP/BP Equivalent to 500 mg High-Dose ICU Protocol Excipients Sodium Phosphate / Sodium Hydroxide Buffer / pH Adjuster *Pack Sizes: Tray of 1 Vial + 1 Ampoule (WFI), 10 Vials, or 50 Vials.
Product Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.
Active Ingredient Strength Primary Use Hydrocortisone Sodium Succinate USP/BP Equivalent to 100 mg Hydrocortisone Standard Adult / Pediatric Emergency Hydrocortisone Sodium Succinate USP/BP Equivalent to 250 mg Severe Asthma / Sepsis Pulse Hydrocortisone Sodium Succinate USP/BP Equivalent to 500 mg High-Dose ICU Protocol Excipients Sodium Phosphate / Sodium Hydroxide Buffer / pH Adjuster *Pack Sizes: Tray of 1 Vial + 1 Ampoule (WFI), 10 Vials, or 50 Vials.
Mebeverine Tablet
FreeProduct Composition & Available Formats
We supply Mebeverine Hydrochloride in both rapid-acting immediate-release and advanced continuous-release configurations to accommodate customized patient compliance tracking.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mebeverine Hydrochloride IP / BP / USP 135 mg Oral Solid Immediate-Release Film-Coated Tablet Targeted Acute Dosing: Fast-acting formulation designed for standard three-times-daily administration prior to localized food triggers. Mebeverine Hydrochloride IP / BP / USP 200 mg SR Sustained-Release Hydrophilic Polymer Matrix Tablet / Capsule Continuous 24-Hour Coverage: Premium, once- or twice-daily formulation engineered to release active molecules continuously, eliminating nocturnal spikes and maximizing compliance. Paracetamol Caffeine Chlorpheniramine Maleate Phenylephrine Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) optimized for maximum clinical efficacy.
Active Ingredient Strength (per Tablet) Primary Clinical Function Paracetamol (Acetaminophen) 325 mg / 500 mg The Pain & Fever Reliever: Targets aches and chills. Caffeine (Anhydrous) 30 mg The Potentiator: Boosts pain relief and alertness. Chlorpheniramine Maleate 2 mg / 4 mg The Antiallergic: Stops sneezing and runny nose. Phenylephrine HCl 5 mg / 10 mg The Decongestant: Clears blocked sinuses. Paracetamol, Diclofenac Potassium & Caffeine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (often capsule-shaped). The coating masks the bitter taste of Caffeine and the astringency of Diclofenac.
Active Ingredient Strength (Standard) Therapeutic Role Paracetamol IP/BP/USP 325 mg / 500 mg Central Analgesic / Antipyretic Diclofenac Potassium BP/USP 50 mg Rapid Anti-Inflammatory Caffeine Anhydrous BP/USP 30 mg Adjuvant / Vasoconstrictor Excipients Q.S. Microcrystalline Cellulose / HPMC Tizanidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, optimized with a deep score-line to allow for exact 1 mg micro-dosing if required by pediatric or highly sensitive geriatric patients.
Active Ingredient Strength Primary Clinical Use Tizanidine Hydrochloride USP/Ph.Eur. 2 mg (Equivalent to Tizanidine base) MANDATORY INITIATION: Dose titration and mild-to-moderate spasm relief. Excipients Anhydrous Lactose / Microcrystalline Cellulose / Colloidal Silicon Dioxide / Stearic Acid Diluent / Glidant / Lubricant (Engineered for immediate gastric dispersion and precise splitting)







